Literature DB >> 9828917

Autoimmune IDDM in a sporadic MELAS patient with mitochondrial tRNA(Leu(UUR)) mutation.

C N Huang1, S H Jee, J J Hwang, Y F Kuo, L M Chuang.   

Abstract

We report a 28-year-old young male with MELAS syndrome (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes) presenting with two previous episodes of stroke-like manifestation, lactic acidosis and mitochondrial cardiomyopathy. He was also affected with insulin-dependent diabetes mellitus (IDDM), as diagnosed by the experience of diabetic ketoacidosis (DKA), and dependence on insulin therapy. On admission, the serum lactate level was found to be increased to 5.4 mmol/l, and plasma glucose level to 7.9 mmol/l with haemoglobin A1c 8.4%, while he was using insulin 26-30 units per day. Physical examination revealed a short stature male of height of 150 cm and weight of 49 kg. Mild mental retardation with bilateral sensorineural hearing impairment was observed. After glucagon stimulation, C-peptide levels rose from 0.46 nmol/l to 0.53 nmol/l, indicative of impaired insulin secretion. Anti-glutamate decarboxylase (anti-GAD) antibody was positive. In addition, human leucocyte associated antigen (HLA) typing showed DR3 and DR4, suggesting the strong contribution of autoimmunity to the pathogenesis of IDDM in this patient. Moreover, the result of a treadmill exercise test was positive due to inferior wall myocardial ischaemia. Cardiac catheterization and endomyocardial biopsy disclosed a normal coronary angiogram and confirmed the diagnosis of mitochondrial cardiomyopathy. Molecular genetic analysis of his family revealed a sporadic occurrence of mitochondrial DNA (mtDNA) mutation at base pair (bp) 3243. The degree of heteroplasmy of mtDNA mutation from a total of 19 passages of skin-derived fibroblasts from this patient showed a slightly downward trend. This extremely rare case of sporadic MELAS syndrome with autoimmune IDDM harbouring mtDNA mutation highlights the possible pathogenetic role of mtDNA mutations in autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9828917     DOI: 10.1046/j.1365-2265.1998.00455.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

1.  Anti-NMDA receptor antibodies in a case of MELAS syndrome.

Authors:  Carsten Finke; Harald Prüss; Michael Scheel; Florian Ostendorf; Lutz Harms; Kathrin Borowski; Klaus-Peter Wandinger; Christoph J Ploner
Journal:  J Neurol       Date:  2011-09-06       Impact factor: 4.849

Review 2.  Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetes.

Authors:  Roseanne O Yeung; Fady Hannah-Shmouni; Karen Niederhoffer; Mark A Walker
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

3.  Expansion of the clinical and neuroimaging spectrum associated with NDUFS8-related disorder.

Authors:  Milena M Andzelm; Shanti Balasubramaniam; Edward Yang; Alison G Compton; Kate Millington; Jia Zhu; Irina Anselm; Lance H Rodan; David R Thorburn; John Christodoulou; Siddharth Srivastava
Journal:  JIMD Rep       Date:  2022-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.